Market Reports Center

Global Gene Therapy in Oncology Market Size, Status and Forecast 2019-2025


Report Details

Global Gene Therapy in Oncology Market Size, Status and Forecast 2019-2025

SKU QYMAR061946
Category Life Sciences
Publisher QY Research
Pages 100
Published Mar-19
Request Discount Pay by Wire/Invoice

Description

Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. 
In 2018, the global Gene Therapy in Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Therapy in Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy in Oncology development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen Biotherapeutics
Tocagen
UniQure
Ziopharm Oncology

Market segment by Type, the product can be split into
Ex Vivo
In Vivo

Market segment by Application, split into
Hospitals
Diagnostics Centers
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Therapy in Oncology status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy in Oncology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Therapy in Oncology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


News/Press Release

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type (2014-2025)
1.4.2 Ex Vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy in Oncology Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gene Therapy in Oncology Market Size
2.2 Gene Therapy in Oncology Growth Trends by Regions
2.2.1 Gene Therapy in Oncology Market Size by Regions (2014-2025)
2.2.2 Gene Therapy in Oncology Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gene Therapy in Oncology Market Size by Manufacturers
3.1.1 Global Gene Therapy in Oncology Revenue by Manufacturers (2014-2019)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy in Oncology Key Players Head office and Area Served
3.3 Key Players Gene Therapy in Oncology Product/Solution/Service
3.4 Date of Enter into Gene Therapy in Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Therapy in Oncology Market Size by Type (2014-2019)
4.2 Global Gene Therapy in Oncology Market Size by Application (2014-2019)

5 United States
5.1 United States Gene Therapy in Oncology Market Size (2014-2019)
5.2 Gene Therapy in Oncology Key Players in United States
5.3 United States Gene Therapy in Oncology Market Size by Type
5.4 United States Gene Therapy in Oncology Market Size by Application

6 Europe
6.1 Europe Gene Therapy in Oncology Market Size (2014-2019)
6.2 Gene Therapy in Oncology Key Players in Europe
6.3 Europe Gene Therapy in Oncology Market Size by Type
6.4 Europe Gene Therapy in Oncology Market Size by Application

7 China
7.1 China Gene Therapy in Oncology Market Size (2014-2019)
7.2 Gene Therapy in Oncology Key Players in China
7.3 China Gene Therapy in Oncology Market Size by Type
7.4 China Gene Therapy in Oncology Market Size by Application

8 Japan
8.1 Japan Gene Therapy in Oncology Market Size (2014-2019)
8.2 Gene Therapy in Oncology Key Players in Japan
8.3 Japan Gene Therapy in Oncology Market Size by Type
8.4 Japan Gene Therapy in Oncology Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gene Therapy in Oncology Market Size (2014-2019)
9.2 Gene Therapy in Oncology Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy in Oncology Market Size by Type
9.4 Southeast Asia Gene Therapy in Oncology Market Size by Application

10 India
10.1 India Gene Therapy in Oncology Market Size (2014-2019)
10.2 Gene Therapy in Oncology Key Players in India
10.3 India Gene Therapy in Oncology Market Size by Type
10.4 India Gene Therapy in Oncology Market Size by Application

11 Central & South America
11.1 Central & South America Gene Therapy in Oncology Market Size (2014-2019)
11.2 Gene Therapy in Oncology Key Players in Central & South America
11.3 Central & South America Gene Therapy in Oncology Market Size by Type
11.4 Central & South America Gene Therapy in Oncology Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy in Oncology Introduction
12.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Cold Genesys
12.2.1 Cold Genesys Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy in Oncology Introduction
12.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2014-2019)
12.2.5 Cold Genesys Recent Development
12.3 Advantagene
12.3.1 Advantagene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy in Oncology Introduction
12.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2014-2019)
12.3.5 Advantagene Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy in Oncology Introduction
12.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy in Oncology Introduction
12.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Bio-Path Holdings
12.6.1 Bio-Path Holdings Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gene Therapy in Oncology Introduction
12.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2014-2019)
12.6.5 Bio-Path Holdings Recent Development
12.7 CRISPR Therapeutics
12.7.1 CRISPR Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gene Therapy in Oncology Introduction
12.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2014-2019)
12.7.5 CRISPR Therapeutics Recent Development
12.8 Editas Medicine
12.8.1 Editas Medicine Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gene Therapy in Oncology Introduction
12.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2014-2019)
12.8.5 Editas Medicine Recent Development
12.9 Geron Corp
12.9.1 Geron Corp Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gene Therapy in Oncology Introduction
12.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2014-2019)
12.9.5 Geron Corp Recent Development
12.10 Idera Pharmaceuticals
12.10.1 Idera Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gene Therapy in Oncology Introduction
12.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2014-2019)
12.10.5 Idera Pharmaceuticals Recent Development
12.11 Intellia Therapeutics
12.12 Johnson & Johnson
12.13 Marsala Biotech
12.14 Merck
12.15 Mologen AG
12.16 Oncolytics Biotech
12.17 Oncosec
12.18 Oncotelic
12.19 Shenzhen SiBiono GeneTech
12.20 Sillajen Biotherapeutics
12.21 Tocagen
12.22 UniQure
12.23 Ziopharm Oncology

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Figures

List of Tables and Figures

Table Gene Therapy in Oncology Key Market Segments
Table Key Players Gene Therapy in Oncology Covered
Table Global Gene Therapy in Oncology Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gene Therapy in Oncology Market Size Market Share by Type 2014-2025
Figure Ex Vivo Figures
Table Key Players of Ex Vivo
Figure In Vivo Figures
Table Key Players of In Vivo
Table Global Gene Therapy in Oncology Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Diagnostics Centers Case Studies
Figure Research Institutes Case Studies
Figure Gene Therapy in Oncology Report Years Considered
Table Global Gene Therapy in Oncology Market Size 2014-2025 (Million US$)
Figure Global Gene Therapy in Oncology Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gene Therapy in Oncology Market Size by Regions 2014-2025 (Million US$)
Table Global Gene Therapy in Oncology Market Size by Regions 2014-2019 (Million US$)
Table Global Gene Therapy in Oncology Market Share by Regions 2014-2019
Figure Global Gene Therapy in Oncology Market Share by Regions 2014-2019
Figure Global Gene Therapy in Oncology Market Share by Regions 2019
Table Market Top Trends
Table Global Gene Therapy in Oncology Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gene Therapy in Oncology Market Share by Manufacturers (2014-2019)
Figure Global Gene Therapy in Oncology Market Share by Manufacturers in 2018
Table Global Gene Therapy in Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gene Therapy in Oncology Product/Solution/Service
Table Date of Enter into Gene Therapy in Oncology Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Therapy in Oncology Market Size by Type (2014-2019) (Million US$)
Table Global Gene Therapy in Oncology Market Size Share by Type (2014-2019)
Figure Global Gene Therapy in Oncology Market Size Market Share by Type (2014-2019)
Table Global Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table Global Gene Therapy in Oncology Market Size Share by Application (2014-2019)
Figure Global Gene Therapy in Oncology Market Size Market Share by Application (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Market Share by Application in 2018
Figure United States Gene Therapy in Oncology Market Size 2014-2019 (Million US$)
Table United States Key Players Gene Therapy in Oncology Revenue (2018-2019) (Million US$)
Table United States Key Players Gene Therapy in Oncology Market Share (2018-2019)
Table United States Gene Therapy in Oncology Market Size by Type (2014-2019) (Million US$)
Table United States Gene Therapy in Oncology Market Share by Type (2014-2019)
Table United States Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table United States Gene Therapy in Oncology Market Share by Application (2014-2019)
Figure Europe Gene Therapy in Oncology Market Size 2014-2019 (Million US$)
Table Europe Key Players Gene Therapy in Oncology Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Therapy in Oncology Market Share (2018-2019)
Table Europe Gene Therapy in Oncology Market Size by Type (2014-2019) (Million US$)
Table Europe Gene Therapy in Oncology Market Share by Type (2014-2019)
Table Europe Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table Europe Gene Therapy in Oncology Market Share by Application (2014-2019)
Figure China Gene Therapy in Oncology Market Size 2014-2019 (Million US$)
Table China Key Players Gene Therapy in Oncology Revenue (2018-2019) (Million US$)
Table China Key Players Gene Therapy in Oncology Market Share (2018-2019)
Table China Gene Therapy in Oncology Market Size by Type (2014-20189) (Million US$)
Table China Gene Therapy in Oncology Market Share by Type (2014-2019)
Table China Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table China Gene Therapy in Oncology Market Share by Application (2014-2019)
Figure Japan Gene Therapy in Oncology Market Size 2014-2019 (Million US$)
Table Japan Key Players Gene Therapy in Oncology Revenue (2018-2019) (Million US$)
Table Japan Key Players Gene Therapy in Oncology Market Share (2018-2019)
Table Japan Gene Therapy in Oncology Market Size by Type (2014-2019) (Million US$)
Table Japan Gene Therapy in Oncology Market Share by Type (2014-2019)
Table Japan Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table Japan Gene Therapy in Oncology Market Share by Application (2014-2019)
Figure Southeast Asia Gene Therapy in Oncology Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gene Therapy in Oncology Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gene Therapy in Oncology Market Share (2018-2019)
Table Southeast Asia Gene Therapy in Oncology Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy in Oncology Market Share by Type (2014-2019)
Table Southeast Asia Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy in Oncology Market Share by Application (2014-2019)
Figure India Gene Therapy in Oncology Market Size 2014-2019 (Million US$)
Table India Key Players Gene Therapy in Oncology Revenue (2018-2019) (Million US$)
Table India Key Players Gene Therapy in Oncology Market Share (2018-2019)
Table India Gene Therapy in Oncology Market Size by Type (2014-2019) (Million US$)
Table India Gene Therapy in Oncology Market Share by Type (2014-2019)
Table India Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table India Gene Therapy in Oncology Market Share by Application (2014-2019)
Figure Central & South America Gene Therapy in Oncology Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gene Therapy in Oncology Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gene Therapy in Oncology Market Share (2018-2019)
Table Central & South America Gene Therapy in Oncology Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gene Therapy in Oncology Market Share by Type (2014-2019)
Table Central & South America Gene Therapy in Oncology Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gene Therapy in Oncology Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Cold Genesys Company Details
Table Cold Genesys Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure Cold Genesys Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Cold Genesys Recent Development
Table Advantagene Company Details
Table Advantagene Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure Advantagene Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Advantagene Recent Development
Table Amgen Company Details
Table Amgen Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table AstraZeneca Recent Development
Table Bio-Path Holdings Company Details
Table Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure Bio-Path Holdings Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Bio-Path Holdings Recent Development
Table CRISPR Therapeutics Company Details
Table CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure CRISPR Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table CRISPR Therapeutics Recent Development
Table Editas Medicine Company Details
Table Editas Medicine Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure Editas Medicine Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Editas Medicine Recent Development
Table Geron Corp Company Details
Table Geron Corp Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure Geron Corp Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Geron Corp Recent Development
Table Idera Pharmaceuticals Company Details
Table Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2014-2019)(Million US$)
Figure Idera Pharmaceuticals Revenue Growth Rate in Gene Therapy in Oncology Business (2014-2019)
Table Idera Pharmaceuticals Recent Development
Table Intellia Therapeutics Company Details
Table Johnson & Johnson Company Details
Table Marsala Biotech Company Details
Table Merck Company Details
Table Mologen AG Company Details
Table Oncolytics Biotech Company Details
Table Oncosec Company Details
Table Oncotelic Company Details
Table Shenzhen SiBiono GeneTech Company Details
Table Sillajen Biotherapeutics Company Details
Table Tocagen Company Details
Table UniQure Company Details
Table Ziopharm Oncology Company Details
Table Global Gene Therapy in Oncology Market Size by Regions (Million US$) 2019-2025
Figure Global Gene Therapy in Oncology Market Size Share by Regions (2019-2025)
Figure Global Gene Therapy in Oncology Market Size Share by Regions in 2025
Figure United States Gene Therapy in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gene Therapy in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure China Gene Therapy in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gene Therapy in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gene Therapy in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure India Gene Therapy in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gene Therapy in Oncology Market Size Forecast (2019-2025)(Million USD)
Table Global Gene Therapy in Oncology Market Size by Product (2019-2025) (Million US$)
Figure Global Gene Therapy in Oncology Market Size by Product (2019-2025)
Figure Global Gene Therapy in Oncology Market Size by Product in 2025
Table Global Gene Therapy in Oncology Market Size by Application (2019-2025) (Million US$)
Figure Global Gene Therapy in Oncology Market Size by Application (2019-2025)
Figure Global Gene Therapy in Oncology Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl